Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 May 2019 | Story Ruan Bruwer | Photo Zimbio
Simoné Gouws
Simoné Gouws (right) in action for the Protea hockey team last year. The defender will be a key player for the Kovsie team in the Varsity hockey competition.

The coach of the first women’s hockey team of the University of the Free State is confident that they can do well in the upcoming Varsity hockey tournament.

The competition works on a gender-rotation system every year. This will be the fourth term of Varsity hockey for women. The Kovsie women has a good record. In 2013 they ended fourth, in 2015 they were second, and in 2017 fifth.

The Kovsies will be facing the University of Johannesburg (UJ) on Friday 3 May 2019. On Saturday, the Maties is lying in wait and the North-West University on Sunday.

“I am confident that we will be doing well. If each player plays her role very well, we should reach the semi-final stage. We have put in the hard work, with good progress. We have played three matches so far in 2019 and haven’t been on the losing side yet,” said Luke Makeleni, head coach.

In friendlies last month, the Kovsies drew to NWU (0-0), defeated UJ by 3-1, and had a good win (6-0) against the Johannesburg club, Shumbas.

“We have quite an experienced squad, with seven survivors from the previous Varsity hockey competition (in 2017), so they know what is expected,” Makeleni said. He is in his third year of coaching the women.

The Kovsies have several players with national experience. Simoné Gouws made her debut for the Proteas last year. Casey-Jean Botha, Shindré-Lee Simmons, Antonet Louw, and Lizanne Jacobs have all represented the South African U21 team. Botha is also in the Protea squad. 

■ The Kovsie team: Wiané Grobler, Chane Hartel, Mikayla Claassen, Anke Badenhorst, Casey-Jean Botha, Shindré-Lee Simmons, Esté van Schalkwyk, Nadia van Staden, Antonet Louw, Michelle Ngoetjane, Heraldine Olin, Lizanne Jacobs, Refilwe Ralikontsane, Mielanka van Schalkwyk, Nela Mbedu, Simoné Gouws, Frances Louw, Kia-Leigh Erasmus.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept